GlassScriptPhysician profile
Kasey P Keene
NPI 1013332246
$3,982.13
in general payments reported to CMS, 2019-2025
29 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $660 · 2023: $739 · 2024: $915 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,949 · Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,948.67 |
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $604.25 | 2022-2025 | Erleada |
| Astellas Pharma US INC | $500.53 | 2021-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $477.71 | 2021-2025 | Provenge |
| Sumitomo Pharma America, INC. | $321.50 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $272.38 | 2022-2025 | |
| Boston Scientific Corporation | $247.05 | 2022-2025 | Xpeeda Dsl Fiber, Lithovue, Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $242.55 | 2022-2025 | |
| Blue Earth Diagnostics | $207.78 | 2021-2024 | |
| Axonics, INC. | $138.68 | 2022-2024 | Axonics |
| Accord Healthcare, INC. | $125.90 | 2024-2025 | |
| Olympus America INC. | $119.63 | 2023-2025 | Itind System |
| Merck Sharp & Dohme LLC | $91.42 | 2023-2025 | Lynparza, Welireg, Keytruda |
| Urovant Sciences INC | $76.15 | 2021-2022 | |
| Immunitybio, INC. | $65.15 | 2025 | |
| Bioprotect Medical, INC. | $59.24 | 2024-2025 | Bioprotect Balloon Implant System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $57.57 | 2021-2024 | Lynparza |
| Medtronic, INC. | $57.48 | 2024-2025 | Interstim |
| Pfizer INC. | $39.99 | 2024 | |
| Progenics Pharmaceuticals, INC. | $37.89 | 2023 | Pylarify |
| Myriad Genetic Laboratories, INC. | $37.52 | 2023-2024 | Prolaris |
| Coloplast Corp | $32.49 | 2022-2023 | Titan |
| Tempus Ai, INC | $28.61 | 2025 | Xt Cdx |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Ethicon US, LLC | $22.26 | 2025 | Echelon; Endopath |
| Urogen Pharma, INC. | $19.75 | 2025 | |
| Endo USA, INC. | $19.13 | 2024 | Xiaflex |
| Endo Pharmaceuticals INC. | $19.04 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.86 | 2022 | |
| Caris Mpi, INC. | $17.69 | 2025 | Mi Cancer Seek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kasey Keene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.